Loading
Prenuvo
Prenuvo is a health technology company that specializes in advanced, radiation-free, and contrast-free whole-body MRI scans aimed at the early detection of cancer and other diseases. Founded in 2018, Prenuvo has its headquarters in Redwood City, California, with additional operations in Los Angeles and San Francisco. The company operates a network of patient-centric clinics across North America, Australia, and the UK, serving over 110,000 members and providing more than 1.4 million personalized health insights. Prenuvo's flagship service is the Whole-Body MRI Scan, which can detect early signs of over 500 types of cancers and diseases in under 60 minutes. The company has recently expanded its offerings to include new FDA-cleared health evaluations, such as a Comprehensive Blood Test, Neurological Scan, and Body Composition Analysis. Prenuvo's focus on preventive healthcare and its use of AI-driven analysis position it as a leader in the diagnostic imaging industry, promoting proactive health management for individuals and organizations alike.
Funding
Every round, secondary, debt facility or acquisition involving Prenuvo that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$143M